Drug Profile
Nephrostat
Alternative Names: NephrostatLatest Information Update: 04 Feb 2008
Price :
$50
*
At a glance
- Originator CollaGenex Pharmaceuticals
- Class
- Mechanism of Action Collagenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic complications; Diabetic nephropathies
Most Recent Events
- 21 May 2003 No development reported - Preclinical for Diabetic complications in USA (unspecified route)
- 21 May 2003 No development reported - Preclinical for Diabetic nephropathies in USA (unspecified route)
- 04 May 2000 Preclinical development for Diabetic complications in USA (Unknown route)